SAKAR

Sakar Healthcare Share Price

 

 

Start SIP in SAKAR

Start SIP

Performance

  • Low
  • ₹381
  • High
  • ₹412
  • 52 Week Low
  • ₹210
  • 52 Week High
  • ₹444
  • Open Price₹408
  • Previous Close₹409
  • Volume30,663
  • 50 DMA₹395.55
  • 100 DMA₹380.60
  • 200 DMA₹358.55

Investment Returns

  • Over 1 Month -8.62%
  • Over 3 Month + 8.94%
  • Over 6 Month + 5.4%
  • Over 1 Year + 28.76%

Smart Investing Starts Here Start SIP with Sakar Healthcare for Steady Growth!

Invest Now

Sakar Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 44.3
  • PEG Ratio
  • 0.8
  • Market Cap Cr
  • 864
  • P/B Ratio
  • 2.8
  • Average True Range
  • 20.92
  • EPS
  • 8.79
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.23
  • RSI
  • 44.19
  • MFI
  • 59.31

Sakar Healthcare Financials

Sakar Healthcare Technicals

EMA & SMA

Current Price
₹388.20
-20.4 (-4.99%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹401.34
  • 50 Day
  • ₹395.55
  • 100 Day
  • ₹380.60
  • 200 Day
  • ₹358.55

Resistance and Support

393.62 Pivot Speed
  • R3 436.88
  • R2 424.27
  • R1 406.23
  • S1 375.58
  • S2 362.97
  • S3 344.93

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sakar Healthcare has an operating revenue of Rs. 203.96 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 12% is healthy, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 19%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 17% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 54 which is a POOR score indicating inconsistency in earnings, a RS Rating of 88 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 77 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sakar Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-07 Quarterly Results & Others To consider other business matters.
2025-07-25 Quarterly Results & Others To consider other business matters.
2025-05-15 Audited results
2025-02-08 Quarterly Results
2024-10-22 Quarterly Results

Sakar Healthcare F&O

Sakar Healthcare Shareholding Pattern

52.86%
13.05%
16.59%
17.5%

About Sakar Healthcare

  • NSE Symbol
  • SAKAR
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Sanjay S Shah
  • ISIN
  • INE732S01012

Similar Stocks to Sakar Healthcare

Sakar Healthcare FAQs

Sakar Healthcare share price is ₹388 As on 26 January, 2026 | 05:04

The Market Cap of Sakar Healthcare is ₹863.7 Cr As on 26 January, 2026 | 05:04

The P/E ratio of Sakar Healthcare is 44.3 As on 26 January, 2026 | 05:04

The PB ratio of Sakar Healthcare is 2.8 As on 26 January, 2026 | 05:04

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23